Literature DB >> 22169623

Identification of the heparin binding site on adeno-associated virus serotype 3B (AAV-3B).

Thomas F Lerch1, Michael S Chapman.   

Abstract

Adeno-associated virus is a promising vector for gene therapy. In the current study, the binding site on AAV serotype 3B for the heparan sulfate proteoglycan (HSPG) receptor has been characterized. X-ray diffraction identified a disaccharide binding site at the most positively charged region on the virus surface. The contributions of basic amino acids at this and other sites were characterized using site-directed mutagenesis. Both heparin and cell binding are correlated to positive charge at the disaccharide binding site, and transduction is significantly decreased in AAV-3B vectors mutated at this site to reduce heparin binding. While the receptor attachment sites of AAV-3B and AAV-2 are both in the general vicinity of the viral spikes, the exact amino acids that participate in electrostatic interactions are distinct. Diversity in the mechanisms of cell attachment by AAV serotypes will be an important consideration for the rational design of improved gene therapy vectors.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22169623      PMCID: PMC3253896          DOI: 10.1016/j.virol.2011.10.007

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  39 in total

Review 1.  Progress in the use of adeno-associated viral vectors for gene therapy.

Authors:  Hildegard Büning; Markus Braun-Falco; Michael Hallek
Journal:  Cells Tissues Organs       Date:  2004       Impact factor: 2.481

Review 2.  Gene therapy progress and prospects: recombinant adeno-associated virus (rAAV) vectors.

Authors:  T R Flotte
Journal:  Gene Ther       Date:  2004-05       Impact factor: 5.250

3.  Effect of errors, redundancy, and solvent content in the molecular replacement procedure for the structure determination of biological macromolecules.

Authors:  E Arnold; M G Rossmann
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

4.  Structural characterization of the dual glycan binding adeno-associated virus serotype 6.

Authors:  Robert Ng; Lakshmanan Govindasamy; Brittney L Gurda; Robert McKenna; Olga G Kozyreva; R Jude Samulski; Kristin N Parent; Timothy S Baker; Mavis Agbandje-McKenna
Journal:  J Virol       Date:  2010-09-22       Impact factor: 5.103

5.  Large-scale production, purification and crystallization of wild-type adeno-associated virus-2.

Authors:  Qing Xie; Joan Hare; Joy Turnigan; Michael S Chapman
Journal:  J Virol Methods       Date:  2004-12-01       Impact factor: 2.014

6.  Identification of a heparin-binding motif on adeno-associated virus type 2 capsids.

Authors:  A Kern; K Schmidt; C Leder; O J Müller; C E Wobus; K Bettinger; C W Von der Lieth; J A King; J A Kleinschmidt
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

Review 7.  Receptor targeting of adeno-associated virus vectors.

Authors:  H Büning; M U Ried; L Perabo; F M Gerner; N A Huttner; J Enssle; M Hallek
Journal:  Gene Ther       Date:  2003-07       Impact factor: 5.250

8.  Crystal structures of the heparan sulfate-binding domain of follistatin. Insights into ligand binding.

Authors:  C Axel Innis; Marko Hyvönen
Journal:  J Biol Chem       Date:  2003-07-16       Impact factor: 5.157

9.  RGD inclusion in VP3 provides adeno-associated virus type 2 (AAV2)-based vectors with a heparan sulfate-independent cell entry mechanism.

Authors:  Wenfang Shi; Jeffrey S Bartlett
Journal:  Mol Ther       Date:  2003-04       Impact factor: 11.454

Review 10.  Advances in AAV-mediated gene transfer for the treatment of inherited disorders.

Authors:  Markus Hildinger; Alberto Auricchio
Journal:  Eur J Hum Genet       Date:  2004-04       Impact factor: 4.246

View more
  25 in total

1.  Structure of AAV-DJ, a retargeted gene therapy vector: cryo-electron microscopy at 4.5 Å resolution.

Authors:  Thomas F Lerch; Jason K O'Donnell; Nancy L Meyer; Qing Xie; Kenneth A Taylor; Scott M Stagg; Michael S Chapman
Journal:  Structure       Date:  2012-06-21       Impact factor: 5.006

Review 2.  E Pluribus Unum: 50 Years of Research, Millions of Viruses, and One Goal--Tailored Acceleration of AAV Evolution.

Authors:  Dirk Grimm; Sergei Zolotukhin
Journal:  Mol Ther       Date:  2015-09-21       Impact factor: 11.454

3.  Characterization of interactions between heparin/glycosaminoglycan and adeno-associated virus.

Authors:  Fuming Zhang; Javier Aguilera; Julie M Beaudet; Qing Xie; Thomas F Lerch; Omar Davulcu; Wilfredo Colón; Michael S Chapman; Robert J Linhardt
Journal:  Biochemistry       Date:  2013-08-28       Impact factor: 3.162

Review 4.  Parvovirus glycan interactions.

Authors:  Lin-Ya Huang; Sujata Halder; Mavis Agbandje-McKenna
Journal:  Curr Opin Virol       Date:  2014-07-19       Impact factor: 7.090

5.  Using a barcoded AAV capsid library to select for clinically relevant gene therapy vectors.

Authors:  Katja Pekrun; Gustavo De Alencastro; Qing-Jun Luo; Jun Liu; Youngjin Kim; Sean Nygaard; Feorillo Galivo; Feijie Zhang; Ren Song; Matthew R Tiffany; Jianpeng Xu; Matthias Hebrok; Markus Grompe; Mark A Kay
Journal:  JCI Insight       Date:  2019-11-14

6.  Adeno-associated viral vectors based on serotype 3b use components of the fibroblast growth factor receptor signaling complex for efficient transduction.

Authors:  Emily L Messina; Jeffrey Nienaber; Mani Daneshmand; Nestor Villamizar; Jude Samulski; Carmelo Milano; Dawn E Bowles
Journal:  Hum Gene Ther       Date:  2012-08-27       Impact factor: 5.695

7.  The threefold protrusions of adeno-associated virus type 8 are involved in cell surface targeting as well as postattachment processing.

Authors:  Christina Raupp; Matthias Naumer; Oliver J Müller; Brittney L Gurda; Mavis Agbandje-McKenna; Jürgen A Kleinschmidt
Journal:  J Virol       Date:  2012-06-20       Impact factor: 5.103

8.  Effects of Altering HSPG Binding and Capsid Hydrophilicity on Retinal Transduction by AAV.

Authors:  Sean M Crosson; Antonette Bennett; Diego Fajardo; James J Peterson; Hangning Zhang; Wei Li; Matthew T Leahy; Colin K Jennings; Ryan F Boyd; Sanford L Boye; Mavis Agbandge-McKenna; Shannon E Boye
Journal:  J Virol       Date:  2021-03-03       Impact factor: 5.103

9.  Structure of neurotropic adeno-associated virus AAVrh.8.

Authors:  Sujata Halder; Kim Van Vliet; J Kennon Smith; Thao Thi Phuong Duong; Robert McKenna; James M Wilson; Mavis Agbandje-McKenna
Journal:  J Struct Biol       Date:  2015-08-31       Impact factor: 2.867

Review 10.  Perspective on Adeno-Associated Virus Capsid Modification for Duchenne Muscular Dystrophy Gene Therapy.

Authors:  Michael E Nance; Dongsheng Duan
Journal:  Hum Gene Ther       Date:  2015-10-15       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.